Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Amortization of Deferred Charges (2023 - 2025)

Q32 Bio (QTTB) has 3 years of Amortization of Deferred Charges data on record, last reported at $37000.0 in Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges fell 24.49% year-over-year to $37000.0; the TTM value through Dec 2025 reached $180000.0, down 7.22%, while the annual FY2025 figure was $180000.0, 7.22% down from the prior year.
  • Amortization of Deferred Charges reached $37000.0 in Q4 2025 per QTTB's latest filing, down from $46000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $66000.0 in Q2 2024 and bottomed at $7000.0 in Q3 2023.
  • Average Amortization of Deferred Charges over 3 years is $38416.7, with a median of $41500.0 recorded in 2025.
  • Peak YoY movement for Amortization of Deferred Charges: skyrocketed 614.29% in 2024, then dropped 25.76% in 2025.
  • A 3-year view of Amortization of Deferred Charges shows it stood at $30000.0 in 2023, then soared by 63.33% to $49000.0 in 2024, then fell by 24.49% to $37000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $37000.0 in Q4 2025, $46000.0 in Q3 2025, and $49000.0 in Q2 2025.